A largely uniform approach to the use of metformin and insulin in the management of Type 2 diabetes in pregnancy has resulted in a lack of studies evaluating optimal dosing or regimens that may optimise glycaemia. The gene discussed is INS; the disease is type 2 diabetes mellitus.